News
14 November 2018
Cambridge Cognition signs new eCOA contracts
Cambridge Cognition today announced it has won a significant new phase IV clinical trial contract for use of its electronic clinical outcomes assessment (eCOA) platform, CANTAB Connect.
Read on
13 September 2018
NeuroVocalix platform ready for clinical trials
NeuroVocalix enables novel voice-based cognitive assessments to be delivered directly to patients through mobile and tele-health platforms, helping to improve outcomes in clinical trials, aid clinical decision-making and play an important role in the management of long-term conditions such as chronic pain.
Read on
1 August 2018
Healthy Amplified launch new population health platform with CANTAB technology
Healthy Amplified are using CANTAB® technology to expand their population health platform offering to adults.
Read on
28 June 2018
CANTAB technology selected for world’s largest dementia study
We are pleased to announce our partnership with Dementias Platform UK (DPUK), the world’s largest study group in dementia research formed to accelerate the development of effective, and ultimately preventative, treatments for diseases such as Alzheimer’s.
Read on
20 June 2018
New product to improve workplace mental health
We are very pleased to announce a planned new software product to assess mental health and wellbeing at work, CANTAB BrainHealth™.
Read on
7 June 2018
Cambridge Cognition and University of Bristol in partnership to tackle growing mental health need
Mental and substance use disorders are now the leading cause of disability worldwide, resulting in 23% of all years lost with a global economic loss of a trillion US dollars every year1 which is why we are very pleased to announce a new strategic collaboration and partnership with the University of Bristol to accelerate the development of novel brain health products.
